Paul Kerr

Losses at Fusion Antibodies quadruple in ‘challenging’ period

Belfast pharmaceutical company did not recommend the payment of a dividend

Fusion Antibodies reports £700,000 loss for first trading year

Belfast company says results show ‘strong organic growth’

Fusion Antibodies raises £5.5m in London Stock Exchange debut

Belfast company to use funds to expand laboratory space and develop new service lines

RBAI dig deep to deny Methody

Inst secure a hat-trick of titles in hard-fought Ulster Schools final

Innovation finalists: making a difference in medical industry

Caterpillar blood clots, fooling the immune system and online doctors

Most Read

1

‘My curiosity made me want to meet the wife of the man I was having an affair with’

2

‘I feel upset and rejected by the coldness of my partner’s father towards me’

3

Hate airports but need to get to London? Here’s a calmer, cheaper, greener way to go

4

Clonliffe has gone and the Irish Catholic Church may not be far behind it

5

Businesses and homes flooded in Wexford after intense rainfall ends heatwave

You may also like...

Listen

Audio versions of the best journalism from The Irish Times

The Irish Times ePaper